Skip to content

Clinical trials

Terminated Phase 3 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 3 Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20071
20081
20151
20172
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Cedars-Sinai Medical Center1
Dr. Roumen Milev1
Hannover Medical School1
Marion Trousselard1
Massachusetts General Hospital1
Pascoe Pharmazeutische Praeparate GmbH1
University Hospital, Brest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders9
Cerebral Palsy1
Dementia1
Depressive Disorder1
Generalized Anxiety Disorder1
Pain1
Psychophysiologic Disorders1
Schizophrenia1
Stress Disorders, Post-Traumatic1
Stress Disorders, Traumatic, Acute1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.